ArticleBMC research notes2026

Tolerability and safety of magrolimab (ONO-7913) in Japanese patients with advanced or metastatic solid tumors: a phase 1, open-label, uncontrolled, dose-escalation study.

Takafumi Koyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.